Share this page:
Independent Director | Audit | Nominating and Governance | Compensation | |
---|---|---|---|---|
J. Kevin Buchi | Independent Director | Audit | ||
Stephen Doberstein, Ph.D. | Independent Director | Nominating and Governance | ||
Martin Freed, M.D. | Independent Director | Nominating and Governance | ||
Patrick Gray | Independent Director | Audit | ||
Stephen J. Hoffman, M.D., Ph.D. | Independent Director | Audit | ||
Adam M. Koppel M.D., Ph.D. | Independent Director | Compensation | ||
Marc Kozin | Independent Director | Compensation | ||
Anna Protopapas | Independent Director | Compensation | ||
Cynthia Smith | Independent Director | Nominating and Governance |
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.